Publication

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Natalie K. Fan, Georgia Institute of TechnologyPhilip M. Keegan, Georgia Institute of TechnologyManu Platt, Emory UniversityRodney D. Averett, Georgia Institute of Technology
Language
  • English
Date
  • 2015-04-01
Publisher
  • Journal of Visualized Experiments (JoVE)
Publication Version
Copyright Statement
  • © 2015 Journal of Visualized Experiments
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1940-087X
Volume
  • 2015
Issue
  • 98
Start Page
  • e52019
End Page
  • e52019
Grant/Funding Information
  • Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number K01HL115486 and by New Innovator Grant 1DP2OD007433-01 from the Office of the Director, National Institutes of Health.
Abstract
  • Fibrin is an extracellular matrix protein that is responsible for maintaining the structural integrity of blood clots. Much research has been done on fibrin in the past years to include the investigation of synthesis, structure-function, and lysis of clots. However, there is still much unknown about the morphological and structural features of clots that ensue from patients with disease. In this research study, experimental techniques are presented that allow for the examination of morphological differences of abnormal clot structures due to diseased states such as diabetes and sickle cell anemia. Our study focuses on the preparation and evaluation of fibrin clots in order to assess morphological differences using various experimental assays and confocal microscopy. In addition, a method is also described that allows for continuous, real-time calculation of lysis rates in fibrin clots. The techniques described herein are important for researchers and clinicians seeking to elucidate comorbid thrombotic pathologies such as myocardial infarctions, ischemic heart disease, and strokes in patients with diabetes or sickle cell disease.
Author Notes
Keywords
Research Categories
  • Engineering, Biomedical

Tools

Relations

In Collection:

Items